1. Home
  2. MYND vs MAIA Comparison

MYND vs MAIA Comparison

Compare MYND & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • MAIA
  • Stock Information
  • Founded
  • MYND 1998
  • MAIA 2018
  • Country
  • MYND United States
  • MAIA United States
  • Employees
  • MYND N/A
  • MAIA N/A
  • Industry
  • MYND Other Consumer Services
  • MAIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • MAIA Health Care
  • Exchange
  • MYND Nasdaq
  • MAIA Nasdaq
  • Market Cap
  • MYND 42.3M
  • MAIA 46.7M
  • IPO Year
  • MYND 2017
  • MAIA 2022
  • Fundamental
  • Price
  • MYND $0.88
  • MAIA $1.78
  • Analyst Decision
  • MYND
  • MAIA
  • Analyst Count
  • MYND 0
  • MAIA 0
  • Target Price
  • MYND N/A
  • MAIA N/A
  • AVG Volume (30 Days)
  • MYND 12.3K
  • MAIA 425.1K
  • Earning Date
  • MYND 03-26-2025
  • MAIA 08-08-2025
  • Dividend Yield
  • MYND N/A
  • MAIA N/A
  • EPS Growth
  • MYND N/A
  • MAIA N/A
  • EPS
  • MYND N/A
  • MAIA N/A
  • Revenue
  • MYND $267,380,999.00
  • MAIA N/A
  • Revenue This Year
  • MYND N/A
  • MAIA N/A
  • Revenue Next Year
  • MYND N/A
  • MAIA N/A
  • P/E Ratio
  • MYND N/A
  • MAIA N/A
  • Revenue Growth
  • MYND N/A
  • MAIA N/A
  • 52 Week Low
  • MYND $0.61
  • MAIA $1.40
  • 52 Week High
  • MYND $3.89
  • MAIA $4.24
  • Technical
  • Relative Strength Index (RSI)
  • MYND 56.43
  • MAIA 50.97
  • Support Level
  • MYND $0.81
  • MAIA $1.60
  • Resistance Level
  • MYND $1.00
  • MAIA $1.95
  • Average True Range (ATR)
  • MYND 0.10
  • MAIA 0.10
  • MACD
  • MYND 0.00
  • MAIA 0.00
  • Stochastic Oscillator
  • MYND 73.68
  • MAIA 54.49

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: